FDA Inspects Sun Pharma Injectables Facility

Source: Bloomberg|Quint

Nov 13, 2017

The U.S. Federal Drug Administration is said to be conducting a surprise inspection at the Baska plant of Sun Pharmaceuticals Ltd., two unnamed sources told BloombergQuint.

The injectables division recently filed for approvals to sell its products in the United States, the story said. It’s close to the drugmaker’s Halol plant, which faces regulatory issues from the FDA.

Read the full story

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments